| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/31/2001 | CN1319659A Novel polypeptide-human lysyloxidase 33 and polynucleotide for encoding said polypeptide |
| 10/31/2001 | CN1319431A Method for improving antitumor activity of amarogentin substance and its composition and evaluation method |
| 10/30/2001 | US6310197 Nucleotide sequences for use in treatment of alzheimer's disease |
| 10/30/2001 | US6310194 Nucleotide sequences which code enzymatic polypetide; for use in controlling hydroxylation in transgenic plants |
| 10/30/2001 | US6310190 USPA1 and USPA2 antigens of Moraxella catarrhalis |
| 10/30/2001 | US6310189 Nucleotides and analogs having photoremoveable protecting groups |
| 10/30/2001 | US6310182 Polypeptide for use in treatment of intracellular vesicular defects |
| 10/30/2001 | US6310181 Adaptor protein FRS2 and related products and methods |
| 10/30/2001 | US6310044 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 10/30/2001 | US6309883 Methods and compositions for cellular and metabolic engineering |
| 10/30/2001 | US6309876 Expression vector for propagation of cells in nervous system; for treating nervous system damage; gene therapy |
| 10/30/2001 | US6309853 Nucleotide sequences coding polypeptide associated with contolling bdy weight; for use in diagnosis and treatment of eating disorders |
| 10/30/2001 | US6309852 Method and reagent for quantitative determination of 1,5-anhydroglucitol |
| 10/30/2001 | US6309851 Generating genetically engineered polypeptide; transform cells, culture cells, recover genetically engineered polypeptide |
| 10/30/2001 | US6309850 Measuring preferential enzyme concentration in fluid; split proenzyme into active enzyme, incubate enzyme with substrate, measure adjustment in optical density and determine enzyme concentration |
| 10/30/2001 | US6309841 Expression vector for the generation of stable genetically engineered polypeptides |
| 10/30/2001 | US6309840 Polymerase chain reaction-restriction fragment length polymorphism test for the authentication of herbal Chinese medicines |
| 10/30/2001 | US6309839 Detection modulators of enzyme activity; mix enzyme and modulator, incubate, monitor adjustment in biotin dissociation |
| 10/30/2001 | US6309838 Monitoring nucleotide sequences for damage; incubate sample with proteins associated with nucleotide sequence breaks, label protein and monitor sample for signal |
| 10/30/2001 | US6309837 Evaluating the geneotype of disease resistant plant; remove tissue from plant, extract nucleotide sequences, replicate nucleotides sequences, amplify and analyze sequences |
| 10/30/2001 | US6309836 Contacting target nucleic acid with primer so primer anneals to nucleic acid in sequence specific manner, incorporating hydrocarbyldithiomethyl-modified nucleotide into primer, detecting modified nucleotide, identifying sequence of base |
| 10/30/2001 | US6309835 Determining the efficiency of mouth therapy; incubate test surface with saliva, bind cells to surface to form film, join film to prosthesis, incubate tooth prosthesis with mouth therapy, count displaced cells |
| 10/30/2001 | US6309834 Detecting homogeneity in nucleotide sequences; generate clones in cells, generate ribonucleic acids, amplify and resolve nucleotide sequences, clone preferential sequences into plasmid, determine sequence of preferential clones |
| 10/30/2001 | US6309833 Strand displacement amplification of nucleotide sequences; join nucleotide sequences to chip, amplify and nucleotide sequences and form amplicons, confine amplicons to preferential positions, detect amplicons |
| 10/30/2001 | US6309829 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 10/30/2001 | US6309827 Detecting genomic marker and extracellular particles; recover sample, obtain genomic marker from the solid support, detect preferential particles and genomic markers |
| 10/30/2001 | US6309826 Diagnosing tumors; monitor tumorous tissue for nucleotide sequences coding tumor glycoprotein, compare to amount of nucleotide sequences coding tumor glycoprotein in healthy sample, classify cells |
| 10/30/2001 | US6309825 Analytical and therapeutic agents |
| 10/30/2001 | US6309824 Analyzing preferential nucleotide sequences; mix nucleotide sequences and probes, incubate target nucleotide sequences with immobilized nucleotide sequences, join immoblized and labeled probes, detect bound target nucleotide sequences |
| 10/30/2001 | US6309823 Nucleotide sequence immobilized on solid support; for use as tool in genetic engineering |
| 10/30/2001 | US6309822 Detecting adjustments in nucleotide sequences; provide probes, mix probes with nucleic acids, detect binding of probes to preferential nucleotide sequences |
| 10/30/2001 | US6309820 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 10/30/2001 | US6309819 Diagnostic and therapeutic system for Crohn's disease and Colitia ulcerosa |
| 10/30/2001 | US6309817 Identifying substances that repress or prevent or attenuate virulence gene expression in an infectious microorganism and phenotypically convert it to a non-pathogen; simplification, accuracy |
| 10/30/2001 | US6309651 A method of inhibiting, moderating or diagnosing pseudomonas aeruginosa infection is disclosed. |
| 10/30/2001 | US6309645 A method of suppressing an immune response in a mammal. |
| 10/30/2001 | US6309644 Parasitic nematode transglutaminase proteins and uses thereof |
| 10/30/2001 | US6309643 Diagnosis and treatment of inflammatory bowel disease using microbial antigens. |
| 10/30/2001 | US6309641 Which can be used immunologically as a vaccine for leptospirosis caused by this organism. |
| 10/30/2001 | US6309602 Stacked, reconfigurable system for electrophoretic transport of charged materials |
| 10/30/2001 | US6309601 Scanning optical detection system |
| 10/30/2001 | CA2170143C Cell death regulator |
| 10/30/2001 | CA2162568C Method and reagent for simultaneously assaying one or more ligands in a group of preselected ligands |
| 10/30/2001 | CA2002902C Rapid method for determining efficacy of a sterilization cycle and rapid read-out biological indicator |
| 10/25/2001 | WO2001079974A2 Haplotypes of the f9 gene |
| 10/25/2001 | WO2001079855A2 Method for quantification of akt protein expression |
| 10/25/2001 | WO2001079853A2 Test system for characterizing modulators of the splicing process of mrna in living cells (in vivo), production thereof and use thereof |
| 10/25/2001 | WO2001079845A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 10/25/2001 | WO2001079563A2 Degradable nucleic acid probes and nucleic acid detection methods |
| 10/25/2001 | WO2001079562A1 Aptamer based two-site binding assay |
| 10/25/2001 | WO2001079561A2 Alpha-2 adrenergic receptor polymorphisms |
| 10/25/2001 | WO2001079560A2 Medicine response assay in respiratory disease |
| 10/25/2001 | WO2001079558A1 High-throughput screening of expressed dna libraries in filamentous fungi |
| 10/25/2001 | WO2001079557A2 Gtp-binding protein useful in treatment and detection of cancer |
| 10/25/2001 | WO2001079556A2 Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers |
| 10/25/2001 | WO2001079555A2 Roles of jak/stat family members in tolerance induction |
| 10/25/2001 | WO2001079554A1 Genetic diagnosis for qt prolongation related adverse drug reactions |
| 10/25/2001 | WO2001079552A1 Haplotypes of the hsd3b1 gene |
| 10/25/2001 | WO2001079551A1 Haplotypes of the nat1 gene |
| 10/25/2001 | WO2001079550A2 Genetic testing for determining the risk of pouchitis development |
| 10/25/2001 | WO2001079548A2 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction |
| 10/25/2001 | WO2001079547A1 Haplotypes of the scn2b gene |
| 10/25/2001 | WO2001079546A2 Flavivirus detection and quantification assay |
| 10/25/2001 | WO2001079545A1 Molecular markers |
| 10/25/2001 | WO2001079544A1 Method for attaching oligonucleotide to solid support and the oligonucleotide array prepared by the method thereof |
| 10/25/2001 | WO2001079543A2 Assay for identification of target rna binding compounds |
| 10/25/2001 | WO2001079542A2 Hiv detection assay and reagents therefor |
| 10/25/2001 | WO2001079541A2 Improvements in and relating to analysis of dna samples |
| 10/25/2001 | WO2001079540A2 Methods for measuring drug resistance |
| 10/25/2001 | WO2001079538A2 Cell-binding nucleic acid molecules (aptamers) |
| 10/25/2001 | WO2001079537A2 Test system for detecting a splicing reaction and use thereof |
| 10/25/2001 | WO2001079536A1 Method and apparatus for dna sequencing |
| 10/25/2001 | WO2001079535A2 Enzyme-based regeneration of surface-attached nucleic acids |
| 10/25/2001 | WO2001079534A1 A method of detecting neoplastic or non-neoplastic cells |
| 10/25/2001 | WO2001079532A1 Kit for the determination of l-carnitine in biological fluids and tissues |
| 10/25/2001 | WO2001079531A1 Early diagnosis of miscarriage in human beings |
| 10/25/2001 | WO2001079530A1 Method for determining the concentration of carnitine in fluids |
| 10/25/2001 | WO2001079528A1 Bacteria and bacteriophage detection using immobilized enzyme substrates |
| 10/25/2001 | WO2001079527A2 Sexual fidelity and sex crime verification |
| 10/25/2001 | WO2001079526A2 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 10/25/2001 | WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 10/25/2001 | WO2001079523A2 Method and system for microorganism identification by mass spectrometry-based proteome database searching |
| 10/25/2001 | WO2001079522A2 Screening assay methods and systems using target pooling |
| 10/25/2001 | WO2001079507A2 EXPRESSION-REGULATING SEQUENCES AND EXPRESSION PRODUCTS IN THE FIELD OF FILAMENTOUS FUNGI $i(CHRYSOSPORIUM) |
| 10/25/2001 | WO2001079493A1 New lipid binding protein 2 |
| 10/25/2001 | WO2001079492A2 Lipid binding protein 3 |
| 10/25/2001 | WO2001079485A2 Direct isolation of transposon insertions tagging transcribed portions of genes |
| 10/25/2001 | WO2001079482A1 Gene mapping method |
| 10/25/2001 | WO2001079481A2 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 10/25/2001 | WO2001079479A2 Methods for selective targeting |
| 10/25/2001 | WO2001079468A2 Drug metabolizing enzymes |
| 10/25/2001 | WO2001079465A2 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 10/25/2001 | WO2001079459A2 Polypeptides having haloperoxidase activity |
| 10/25/2001 | WO2001079455A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 10/25/2001 | WO2001079451A1 Methods and compositions for culturing spirochetes and treating spirochetal diseases |
| 10/25/2001 | WO2001079448A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 10/25/2001 | WO2001079421A2 Apparatus and methods for testing effects of materials and surface coatings on the formation of biofilms |
| 10/25/2001 | WO2001079420A2 Detection and amplification or rna using target-mediated ligation of dna by rna ligase |
| 10/25/2001 | WO2001079419A2 Cellular arrays for the identification of altered gene expression |
| 10/25/2001 | WO2001079291A2 Secreted proteins |